-
Stocks Buzz: Idera Pharmaceuticals (NASDAQ:IDRA), Freeport-McMoRan Inc. (NYSE:FCX), The ExOne Company (NASDAQ:XONE), Yandex N.V. (NASDAQ:YNDX), S&W Seed Company (NASDAQ:SANW)
Idera Pharmaceuticals Inc. (IDRA: Quote) announced the U.S. FDA has granted orphan drug designation for IMO-8400, an antagonist of the endosomal Toll-like receptors (TLRs) 7, 8 and 9, for the treatment of Waldenström’s macroglobulinemia. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) in last trading activity moved up 1.03% to close at $4.41. Company weekly performance is 13.95% while…
-
Stocks on the move: ARMOUR Residential REIT (NYSE:ARR), Prospect Capital Corporation (NASDAQ:PSEC), Amtech Systems Inc. (NASDAQ:ASYS), Intersect (NASDAQ:XENT), S&W Seed (NASDAQ:SANW)
MLV & Co restated their hold rating on shares of ARMOUR Residential REIT (NYSE:ARR) in a research note issued to investors on Monday. The firm currently has a $4.00 price target on the stock, down from their previous price target of $4.50. ARMOUR Residential REIT, Inc. (NYSE:ARR) in last trading activity increased 1.36% to close…
-
Market Movers: Galena Biopharma (NASDAQ:GALE), S&W Seed Company (NASDAQ:SANW), Alpha & Omega Semiconductor (NASDAQ:AOSL), Atlantic American (NASDAQ:AAME), Piedmont Natural Gas (NYSE:PNY)
On 11 December Galena Biopharma, Inc. (NASDAQ:GALE) announced that initial immunohistochemistry (IHC) screening data from the NeuVax™ (nelipepimut-S) Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVaxTreatment) trial was presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Galena Biopharma, Inc. (NASDAQ:GALE) in last…
-
Market Movers: Galena Biopharma (NASDAQ:GALE), S&W Seed Company (NASDAQ:SANW), Alpha & Omega Semiconductor (NASDAQ:AOSL), Atlantic American (NASDAQ:AAME), Piedmont Natural Gas (NYSE:PNY)
On 11 December Galena Biopharma, Inc. (NASDAQ:GALE) announced that initial immunohistochemistry (IHC) screening data from the NeuVax™ (nelipepimut-S) Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVaxTreatment) trial was presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Galena Biopharma, Inc. (NASDAQ:GALE) in last…
-
Investors Should Watch: Genworth Financial (NYSE:GNW), Twitter Inc (NYSE:TWTR), S&W Seed Company (NASDAQ:SANW), Cisco Systems (NASDAQ:CSCO), TG Therapeutics (NASDAQ:TGTX)
Shares of Genworth Financial Inc (NYSE:GNW) were the recipient of a large increase in short interest in November. As of November 14th, there was short interest totalling 10,236,097 shares, an increase of 78.2% from the October 31st total of 5,743,310 shares. Genworth Financial, Inc. (NYSE:GNW) in last trading activity advanced 0.98% to close at $8.24.…
-
Market Wrap Up: Seventy Seven Energy Inc. (NYSE:SSE), S&W Seed Company (NASDAQ:SANW), Mentor Graphics Corp. (NASDAQ:MENT), PrimeEnergy (NASDAQ:PNRG), Moelis & Company (NYSE:MC)
Seventy Seven Energy (NYSE:SSE) Director Bob G. Alexander purchased 5,000 shares of Seventy Seven Energy stock on the open market in a transaction that occurred on Friday, December 5th. The stock was purchased at an average cost of $6.18 per share, with a total value of $30,900.00. Seventy Seven Energy Inc. (NYSE:SSE) in last trading…
-
Merck & Co. Inc. (NYSE:MRK) issues statement regarding CUBICIN patent litigation: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), S&W Seed (NASDAQ:SANW), BlackBerry (NASDAQ:BBRY)
Merck& Co. Inc. (NYSE:MRK) issues statement regarding CUBICIN patent litigation; reaffirms Cubist (CBST) transaction to proceed as planned – expected to close in first quarter of 2015. MRK continues to believe the acquisition of Cubist will create strong fundamental value for Merck’s shareholders. Merck & Co. Inc. (NYSE:MRK) in last trading activity decreased -3.02% to…
-
Fast Moving Stocks: Endocyte (NASDAQ:ECYT), J C Penney Company Inc (NYSE:JCP), S&W Seed Company (NASDAQ:SANW), Republic Services (NYSE:RSG), RCPI
On 5 November Endocyte, Inc. (NASDAQ:ECYT) announced financial results for the third quarter ending Sept. 30, 2014. Endocyte reported a net loss of $5.7 million, or $0.14 per basic and diluted share, for the third quarter of 2014, compared to a net loss of $3.0 million, or $0.08 per basic and diluted share, for the…
-
News Buzz: Avon Products Inc. (NYSE:AVP), Huntington Bancshares Incorporated (NASDAQ:HBAN), Casey’s General Stores (NASDAQ:CASY), S&W Seed (NASDAQ:SANW), Haverty Furniture Companies (NYSE:HVT)
On October 30, Avon Products, Inc. (NYSE:AVP) reported third-quarter 2014 results. For the third quarter of 2014, total revenue of $2.1 billion decreased 8%, but increased 1% in constant dollars. Total units decreased 4% and price/mix was up 5% during the quarter. Active Representatives ² were down 4%, while average order ² increased 5%. Avon…
-
Fast Moving Stocks: Merck & Co. Inc. (NYSE:MRK), DryShips (NASDAQ:DRYS), Cedar Realty Trust (NYSE:CDR), S&W Seed (NASDAQ:SANW), Sterling Bancorp. (NYSE:STL)
On 27 October Merck & Co. Inc. (NYSE:MRK) announced mixed financial and operational results for the third quarter of its 2014 fiscal year. The drug brought in revenues of $412 million in the third quarter, lower than the consensus estimate of $455.2 million. Merck & Co. Inc. (NYSE:MRK) in last trading activity moved up 0.76%…